Cancer Cell Biology

You have full text access to this OnlineOpen article

Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids

  1. Thorsten Hoevel1,†,
  2. Robert Macek1,†,
  3. Karen Swisshelm2,
  4. Manfred Kubbies1,‡,*

Article first published online: 28 OCT 2003

DOI: 10.1002/ijc.11571

Issue

International Journal of Cancer

International Journal of Cancer

Volume 108, Issue 3, pages 374–383, 20 January 2004

Additional Information

How to Cite

Hoevel, T., Macek, R., Swisshelm, K. and Kubbies, M. (2004), Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int. J. Cancer, 108: 374–383. doi: 10.1002/ijc.11571

Author Information

  1. 1

    Roche Pharmaceutical Research Oncology, Penzberg, Germany

  2. 2

    Department of Pathology, University Washington, Seattle, WA, USA

  1. †

    The first 2 authors contributed equally to this paper.

  2. ‡

    Fax: +49-8856-60-3068

*Pharmaceutical Research Oncology, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany

Publication History

  1. Issue published online: 21 NOV 2003
  2. Article first published online: 28 OCT 2003
  3. Manuscript Accepted: 8 AUG 2003
  4. Manuscript Revised: 21 JUN 2003
  5. Manuscript Received: 24 JAN 2003

Funded by

  • University of Washington Medical Center Breast program Tennis Tournament

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (562K)

REFERENCES

  • 1
    Gimbrone MA, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972; 136: 261–76.
  • 2
    Ellis LM, Liu W, Ahmad SA, Fan F, Jung YD, Shaheen RM, Reinmuth N. Overview of angiogenesis: biologic implications for antiangiogenic therapy. Semin Oncol 2001; 28: 94–104.
  • 3
    Mullin JM. Potential interplay between luminal growth factors and increased TJ permeability in epithelial carcinogenesis. J Exp Zool 1997; 279: 484–9.
    Direct Link:
  • 4
    Mullin JM, Laughlin KV, Ginanni N, Marano CW, Clarke HM, Soler AP. Increased TJ permeability can result from protein kinase C activation/translocation and act as a tumor promotional event in epithelial cancers. Ann NY Acad Sci 2000; 915: 231–6.
    Direct Link:
  • 5
    Swift JG, Mukherjee TM, Rowland R. Intercellular junctions in hepatocellular carcinoma. J Submicrosc Cytol 1983; 15: 799–810.
  • 6
    Cochand-Priollet B, Raison D, Molinie V, Guillausseau PJ, Wassef M, Bouchaud C. Altered gap and TJs in human thyroid oncocytic tumors: a study of 8 cases by freeze-fracture. Ultrastruct Pathol 1998; 22: 413–20.
  • 7
    Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased TJ permeability is associated with the development of colon cancer. Carcinogenesis 1999; 20: 1425–31.
  • 8
    Alroy J. Ultrastructure of canine urinary bladder carcinoma. Vet Pathol 1979; 16: 693–701.
  • 9
    Robenek H, Schopper C, Fasseke E, Fetting R, Themann HJ. Structure and function of the junctional complement of spontaneous and transplanted murine mammary carcinomas. Submicros Cytol 1981; 13: 347–63.
  • 10
    Hoover KB, Liao SY, Bryant PJ. Loss of the TJ MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998; 153: 1767–73.
  • 11
    Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994; 31: 325–35.
  • 12
    Willott E, Balda MS, Fanning AS, Jameson B, Van Itallie C, Anderson JM. The TJ protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc Natl Acad Sci USA 1993; 90: 7834–8.
  • 13
    Bilder D, Li M, Perrimon N. Cooperative regulation of cell polarity and growth by drosophila tumor suppressors. Science 2000; 289: 113–6.
  • 14
    Balda MS, Matter KJ. Tight junctions. Cell Sci 1998; 111: 541–7.
  • 15
    Tsukita S, Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol 1999; 9: 268–73.
  • 16
    Mitic LL, Van Itallie CM, Anderson JM. Molecular physiology and pathophyiology of TJs: I, TJ structure and function—lessons from mutant animals and proteins. Gastroint Liver Physiol 2000; 279: 250–4.
  • 17
    Heiskala M, Peterson PA, Yang Y. The roles of claudin superfamily proteins in para-cellular flux. Traffic 2001; 2: 92–8.
    Direct Link:
  • 18
    Martin TA, Jiang WG. Tight junctions and their role in cancer metastasis. J Histol Histopathol 2001; 16: 1183–95.
  • 19
    Tsukita S, Furuse M, Itoh M. Multifunctional strands in TJs. Nat Rev Mol Cell Biol 2001; 2: 285–93.
  • 20
    Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at TJs. J Cell Biol 1993; 123: 1777–88.
  • 21
    Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at TJs with no sequence similarity to occludin. J Cell Biol 1998; 141: 1539—50.
  • 22
    Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or –2 reconstitutes TJ strands and recruits occludin in fibroblasts. J Cell Biol 1998; 143: 391–401.
  • 23
    Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of TJ strands. Proc Natl Acad Sci USA 1999; 96: 511–6.
  • 24
    Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, Bronstein JM, Kachar B, Lazzarini RA. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 1999; 99: 649–59.
  • 25
    Simon DB, Lu Y, Croate KA, Velazquez H, Al-Sabban E, Praga M, Casari, et al. Paracellin-1, a renal TJ protein required for paracellular Mg2+ resorption. Science 1999; 285: 103–6.
  • 26
    Swisshelm K, Machl A, Planitzer S, Robertson R, Kubbies M, Hosier S. SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily. Gene 1999; 226: 285–95.
  • 27
    Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, Wolburg H. Claudin-1 and claudin-5 expression and TJ morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol 2000; 100: 323–31.
  • 28
    Long H, Crean CD, Lee WH, Cummings OW, Gabig TG. Expression of clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001; 61: 7878–81.
  • 29
    Tiwari-Woodruff SK, Buznikov AG, Vu TQ, Micevych PE, Chen K, Kornblum HI, Bronstein JM. OSP/claudin-11 forms a complex with a novel member of the tetraspin superfamily and beta1 integrin and regulates proliferation and migration of oligo-dendrocytes. J Cell Biol 2001; 153: 295–305.
  • 30
    Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TN, Ploplis B, et al. Mutations in the gene encoding TJ claudin-14 cause autosomal recessive deafness DFNB29. Cell 2001; 104: 165–72.
  • 31
    Kraemer F, White K, Kubbies M, Swisshelm K, Weber BHF. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum Genet 2000; 107: 249–56.
  • 32
    Hoevel T, Macek R, Mundigl O, Swisshelm K, Kubbies M. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol 2002; 191: 60–8.
    Direct Link:
  • 33
    Inai T, Kobayashi J, Shibata Y. Claudin-1 contributes to the epithelial barrier function in MDCK cells. Eur J Cell Biol 1999; 78: 849–55.
  • 34
    Fukazawa H, Mizuno S, Uehara Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal Biochem 1995; 228: 83–90.
  • 35
    Machl AW, Planitzer S, Kubbies M. A novel, membrane receptor-based retroviral vector for Fanconi anemia group C gene therapy. Gene Ther 1997; 4: 339–45.
  • 36
    Yuhas JM, Tarleton AE. Dormancy and spontaneous recurrence of human breast cancer in vitro. Cancer Res 1978; 38: 3584–9.
  • 37
    Hamilton G. Multicellular spheroids as an in vitro tumor model. Cancer Lett 1998; 131: 29–34.
  • 38
    Kubuta K, Furuse M, Sasaki H, Sonoda N, Fujita K, Nagafuchi A, Tsukita S. Ca2+ independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr Biol 1999; 9: 1035–8.
  • 39
    Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 2001; 12: 469–76.
  • 40
    Furuse M, Furuse K, Sasaki H, Tsukita S. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into madin-darby canine kidney cells. J Cell Biol 2001; 153: 263–72.
  • 41
    Enck AH, Berger UV, Yu AS. Claudin-2 is selectively expressed in proximal nephron in mouse kidney. Am J Physiol 2001; 281: 966–74.
  • 42
    Chen YH, Lu Q, Schneeberger EE, Goodenenough DA. Restoration of TJ structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 2000; 11: 849–62.
  • 43
    Woo PL, Ching D, Guan Y, Firestone GL. Requirement for ras and phosphatidyl-inositol-3-kinase signaling uncouples the glucocorticoid-induced junctional organization and transepithelial resistance in mammary tumor cells. J Biol Chem 1999; 274: 32818–28.
  • 44
    Porvaznik M, Johnson RG, Sheridan JD. TJ development between cultured hepatoma cells: possible stages in assembly and enhancement with dexamethasone. J Supramol Struct 1979; 10: 13–30.
    Direct Link:
  • 45
    Kubota H, Chiba H, Takakuwa Y, Osanai M, Tobioka H, Kohama GI, Mori M, Sawada N. Retinoid X receptor alpha and retinoid acid receptor gamma mediate expression of genes encoding TJ proteins and barier function in F9 cells during visceral endodermal differentiation. Exp Cell Res 2001; 263: 163–72.
  • 46
    Duffy HS, John GR, Lee SC, Brosnan CF, Spray DC. Reciprocal regulation of the junctional proteins claudin-1 and connexin43 by interleukin-1-beta in primary human fetal astrocytes. J Neurosci 2000; 20: 1–6.
  • 47
    Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000; 118: 1001–11.
  • 48
    Mullin JM, Marano CW, Laughlin KV, Nuciglio M, Stevenson BR, Soler P. Different size limitations for increased transepithelial paracellular solute flux across phorbol ester and tumor necrosis factor-treated epithelial cell sheets. J Cell Physiol 1997; 171: 226–33.
    Direct Link:
  • 49
    Mullin JM, Kampherstein JA, Laughlin KV, Saladik DT, Soler AP. Transepithelial paracellular flux leakiness induced by chronic phorbolester exposure correlates with poly-like foci and redistribution of protein kinase C. Carcinogenesis 1997; 18: 2339–45.
  • 50
    Mullin JM, Ginanni N, Laughlin KV. Protein kinase C activation increases trans-epithelial transport of biological active insulin. Cancer Res 1998; 58: 1641–5.
  • 51
    Lippoldt A, Liebner S, Andbjer B, Kalbacher H, Wolburg H, Haller H, Fuxe K. Organization of choroid plexus epithelial and endothelial cell TJs and regulation of claudin-1, -2 and –5 expression by protein kinase C. Neuroreport 2000; 11: 1427–31.
  • 52
    Li D, Mrsny RJ. Oncogenic raf-1 disrupts epithelial TJs via downregulation of occludin. J Cell Biol 2000; 148: 791–800.
View Full Article (HTML) Get PDF (562K)